GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oruka Therapeutics Inc (NAS:ORKA) » Definitions » Interest Expense

ORKA (Oruka Therapeutics) Interest Expense : $ Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Oruka Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Oruka Therapeutics's interest expense for the six months ended in Mar. 2024 was $ 0.00 Mil. Oruka Therapeutics does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Mar. 2024.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Oruka Therapeutics's Operating Income for the six months ended in Mar. 2024 was $ 0.00 Mil. Oruka Therapeutics's Interest Expense for the six months ended in Mar. 2024 was $ 0.00 Mil. GuruFocus does not calculate Oruka Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oruka Therapeutics Interest Expense Historical Data

The historical data trend for Oruka Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oruka Therapeutics Interest Expense Chart

Oruka Therapeutics Annual Data
Trend
Interest Expense

Oruka Therapeutics Semi-Annual Data
Mar24
Interest Expense -

Oruka Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Oruka Therapeutics  (NAS:ORKA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oruka Therapeutics's Interest Expense for the six months ended in Mar. 2024 was $0.00 Mil. Its Operating Income for the six months ended in Mar. 2024 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2024 was $24.98 Mil.

Oruka Therapeutics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Oruka Therapeutics's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Oruka Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oruka Therapeutics Inc (NAS:ORKA) » Definitions » Interest Expense
Comparable Companies
Traded in Other Exchanges
HQ1:Germany
Address
221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Website
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.